Cargando...
A92 ANTI-TNF DOSE AUGMENTATION FREQUENTLY OCCURS IN THE ABSENCE OF OBJECTIVE EVIDENCE OF DISEASE ACTIVITY
BACKGROUND: Anti tumor necrosis factor therapy (anti-TNF) is widely used in patients with moderate to severe CD and UC. When symptoms persist, anti-TNF dose is often increased or the dosing interval shortened. Evidence supporting the effectiveness of dose augmentation is of low quality and dose augm...
Gardado en:
| Publicado en: | J Can Assoc Gastroenterol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6508157/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy009.092 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|